CJC-1295 (Without DAC) Peptide 10MG

CJC-1295 W/O DAC 10MG is a synthetic growth hormone-releasing hormone (GHRH) analog utilized in research settings to study pulsatile growth hormone release and endocrine signaling. Unlike DAC-modified versions, this peptide is characterized by a shorter half-life, making it suitable for investigating natural hormone release patterns and receptor interaction dynamics.

Research Context

CJC-1295 without DAC is commonly explored for its interaction with GHRH receptors, stimulating controlled release of growth hormone in experimental models. It is frequently used in studies examining endocrine regulation, hormone pulsatility, and feedback mechanisms within the hypothalamic-pituitary axis.

Research Overview

Preclinical research involving CJC-1295 W/O DAC focuses on understanding hormone signaling and temporal release patterns. Key areas of investigation include:

• Growth hormone pulsatile release dynamics
• GHRH receptor interaction and activation
• Endocrine system signaling pathways
• Hormonal feedback and regulation mechanisms

Key Research Focus Areas

Pulsatile Hormone Release Studies:
Investigation of short-acting peptide behavior and its role in mimicking natural hormone secretion patterns.

Receptor Binding and Activation:
Analysis of peptide affinity and activity at GHRH receptors in controlled laboratory conditions.

Endocrine System Research:
Evaluation of interactions within the hypothalamic-pituitary axis and downstream signaling effects.

Comparative Peptide Analysis:
Study of differences between DAC and non-DAC variants in terms of duration, activity, and signaling outcomes.

This product is intended strictly for laboratory and research purposes. It is not designed for human or animal use.

For research use only. Not for human or animal consumption.

Store under appropriate laboratory conditions to preserve peptide stability and functional integrity.